Search Site Back Who We Are About Us Our Focus Our Values Our Leadership Our History Awards & Recognition Sustainability Ethics & Compliance News Press Releases Media Contacts Events Join us at these events Investor Relations Investor Relations Related Resources Library Quintiles Cares What We Do Services Consulting Change Management Market Intelligence Portofolio Management & Transaction Services Process & IT Implementation Product Development Strategy Consulting Product Value & Outcomes Strategy Regulatory & Compliance Consulting Portfolio & Strategic Planning Biosimilars Clincal Trial Planning & Design Functional Service Providers Model-Based Drug Development Clinical Trial Execution Clinical Biostatistics Clinical Data Management Early Clinical Dev Phase I/IIa Clinical Trials Phase II/III Clinical Trials Clinical Monitoring Late Phase Clinical Trials Patient Recruitment Project Management Regulatory Affairs Risk-based Monitoring Safety and Pharmacovigilance Site Start-up Laboratories Bioanaly and ADME Laboratories Central Laboratories Genomic Laboratories Real world & Late Phase Real-world & Late Phase Strategy Interventional Phase IIIb/IV Clinical Trials Observational Research & Registries Real-world Data & Analytics Safety and Risk Management Quality Improvement For Providers Specialty Clinical Associations & Patient Organization Patient & Provider Engagement Enhance Product Development Prove Product Value & Safety Accelerate Adoption & Adherence Patient Engagement Services Product Marketing & Sales Product Launch Brand & Scientific Communications Contract Sales Integrate Channel Management Market Access Market Entry/Market Exit Patient Education Related Resources Continuing Medical Education Library Therapeutics Acute Care Cardiovascular Central Nervous System Diabetes Immunology Infectious Diseases Internal Medicine Oncology Early Phase Oncology Translational Oncology Pediatrics Public Health Interest Rare Disease Vaccines Related Resources Library How We Think Vantage Point Evidence and Value Systems-Thinking Payers & Providers Oncology Diabetes Rare Diseases Biosimilars Quintiles Blog Quintiles Blog Quintiles Authors Quintiles Authors Related Resources Library Peer-Reviewed Publications Where We Are Locations United States United Kingdom Belgium Brazil China France Germany Italy Japan Netherlands Poland Portugal Russia Spain Find an Office All Global Locations Contact us Contact us Global Careers Global Careers Who We Are What We Do How We Think Where We Are contact us investors my Quintiles About Us Our Focus Our Values Our Leadership Our History Awards & Recognition Sustainability Ethics & Compliance News Press Releases Media Contacts Events Join us at these events Investor Relations Investor Relations Related Resources Library Quintiles Cares Services Therapeutics Areas Markets Consulting Change Management Market Intelligence Portofolio Management & Transaction Services Process & IT Implementation Product Development Strategy Consulting Product Value & Outcomes Strategy Regulatory & Compliance Consulting Portfolio & Strategic Planning Biosimilars Clincal Trial Planning & Design Functional Service Providers Model-Based Drug Development Clinical Trial Execution Clinical Biostatistics Clinical Data Management Early Clinical Dev Phase I/IIa Clinical Trials Phase II/III Clinical Trials Clinical Monitoring Late Phase Clinical Trials Patient Recruitment Project Management Regulatory Affairs Risk-based Monitoring Safety and Pharmacovigilance Site Start-up Laboratories Bioanaly and ADME Laboratories Central Laboratories Genomic Laboratories Real world & Late Phase Real-world & Late Phase Strategy Interventional Phase IIIb/IV Clinical Trials Observational Research & Registries Real-world Data & Analytics Safety and Risk Management Quality Improvement For Providers Specialty Clinical Associations & Patient Organization Technology Solutions Patient & Provider Engagement Enhance Product Development Prove Product Value & Safety Accelerate Adoption & Adherence Patient Engagement Services Product Marketing & Sales Product Launch Brand & Scientific Communications Contract Sales Integrate Channel Management Market Access Market Entry/Market Exit Patient Education Related Resources Continuing Medical Education Library Acute Care Cardiovascular Central Nervous System Diabetes Immunology Infectious Diseases Internal Medicine Oncology Early Phase Oncology Translational Oncology Pediatrics Public Health Interest Rare Disease Vaccines Related Resources Library Biopharmaceutical R&D Biopharma Sales & Marketing Biosimilars Medical Device & Diagnostics Patient Association Payers and Providers Public Health & Government Small Biopharma Related Resources Library Vantage Point Evidence and Value Systems-Thinking Payers & Providers Oncology Diabetes Rare Diseases Biosimilars Quintiles Blog Quintiles Authors Related Resources Library Peer-Reviewed Publications United States United Kingdom Belgium Brazil China France Germany Italy Japan Netherlands Poland Portugal Russia Spain Find an Office All Global Locations Contact us Global Careers Investor Relations Overview Awards and Recognition Financial Information Stock Information SEC Filings Quarterly Reports Annual Report Interactive Financials and Charts Events & Presentations Press Releases Analyst Coverage Corporate Governance Governance Documents Board of Directors Committee Composition Code of Conduct Procedures for Reporting FAQs Home|Investor Relations Investors Quintiles helps to improve healthcare worldwide by providing a broad range of professional services, information and partnering solutions to the pharmaceutical services, biotechnology and healthcare industries. 100% of 2013's best selling products or compounds Quintiles has helped develop or commercialize 100% of the top 100 products or compounds in 2013. Investor Relations Learn more about Quintiles Investor Relations Investor Relations Overview Awards and Recognition Financial Information Stock Information SEC Filings Quarterly Reports Annual Report Interactive Financials and Charts Events & Presentations Press Releases Analyst Coverage Corporate Governance Governance Documents Board of Directors Committee Composition Code of Conduct Procedures for Reporting FAQs Home > Investor Relations Investor Relations Overview Awards and Recognition Financial Information Stock Information SEC Filings Quarterly Reports Annual Report Interactive Financials and Charts Events & Presentations Press Releases Analyst Coverage Corporate Governance Governance Documents Board of Directors Committee Composition Code of Conduct Procedures for Reporting FAQs NYSE: Q $ 53.20 (COMMON STOCK) Change (%): -1.44 -2.63% Volume: 527,162 20 minute delay October 10, 2014 Recent Press Releases Sep. 30 2014 Quintiles’ Third Quarter 2014 Earnings Call Scheduled for Thursday, October 30th Sep. 12 2014 Quintiles Launches New Customer Solution to Meet the Unique Needs of Emerging Biopharmaceutical Companies Aug. 20 2014 Quintiles CEO to Present at the Morgan Stanley Global Healthcare Conference Quintiles is the world’s largest provider of biopharmaceutical development services and commercial outsourcing services. We are positioned at the intersection of business services and healthcare and generated $3.8 billion of service revenues in 2013, conduct business in approximately 100 countries and have over 30,000 employees. We use the breadth and depth of our service offerings, our global footprint and our therapeutic, scientific and analytics expertise to help our biopharmaceutical customers, as well as other healthcare customers, navigate the increasingly complex healthcare environment to improve efficiency and to deliver better healthcare outcomes. Read More Reports & Presentations Events & Presentations Upcoming EventsPast Events October 30, 2014 Quintiles’ Third Quarter 2014 Earnings Call View the live Webcast Add to Calendar September 8, 2014 Morgan Stanley Global Healthcare Conference Speaker(s): Tom Pike, CEO View the live Webcast View this Presentation (PDF 613 KB) Add to Calendar View All Investor Tools Print Page Email Page Share This Investor Tool Kit Email Alerts Email Address * Mailing Lists * Press Releases SEC Filings Unsubscribe Investor Relations Contact Telephone: +1 919 998 2590 Quintiles Investor Relations 4820 Emperor Boulevard PO Box 13979 Durham, North Carolina 27703 Connect with us Connecting insights Additional Resources RFP/RFI Requests Careers Careers Find an Office Investor Relations Media Relations System Thinking Evidence & Value Expertise Quintiles Blogs Susantability Global Privacy Privacy Policy Statement Terms of Service Quintiles Investigators MediGuard.org ClinicalResearch.com Call Quintiles sales and corporate support: US toll free only: 1-866-267-4479 Please visit http://ww.quintiles.com/contact for international contacts. To continue, please visit http://www.quintiles.com/careers and select the region you wish to apply. Copyright © 1998–2014 Quintiles Inc. All rights reserved. Powered By Q4 Web Systems 4.0.6.245